We have located links that may give you full text access.
Clinical trial of the D.E.L.P.H.I.N. speech treatment for children and adolescents who stutter.
Logopedics, Phoniatrics, Vocology 2018 September 12
PURPOSE: The present trial investigated the D.E.L.P.H.I.N. (Deblockierungsimpuls, Entspannung, Logopädie, Phonetik, Hör-Wahrnehmungstraining, Intensität, nasaler Schwingungsakzent) speech treatment for children and adolescents who stutter, an approach using fluency shaping with an intensive time schedule and group sessions.
METHODS: Participants were 42 male and 14 female persons who stuttered with a median age of 13.0 years. Participants and their parents completed the strength and difficulties questionnaire at the beginning of the therapy and 1 year later. Participants completed the Speech Questionnaire, an instrument to measure the impact of stuttering, twice before and twice after completing the therapy. The stuttering rate and mean length of the three longest stuttering events were studied four times in videos of interviews, reading texts and three telephone calls. Outcomes are reported for the 56 children and young adults who stuttered and who completed D.E.L.P.H.I.N. The main analysis was performed using linear mixed models.
RESULTS: Quality of life as measured in the Strength and Difficulties Questionnaire (SDQ) - filled in by the participants/their parents - increased significantly from before the start of the therapy to 1 year after completion of the therapy. The subjective rating of the impact of stuttering also improved significantly. The stuttering rate and mean length of the longest stuttering event decreased significantly for all three modes from pre-treatment to 12 months post-treatment.
CONCLUSIONS: After D.E.L.P.H.I.N., a significant improvement of the relevant endpoints quality of life, impact of stuttering, and severity of stuttering is observed.
METHODS: Participants were 42 male and 14 female persons who stuttered with a median age of 13.0 years. Participants and their parents completed the strength and difficulties questionnaire at the beginning of the therapy and 1 year later. Participants completed the Speech Questionnaire, an instrument to measure the impact of stuttering, twice before and twice after completing the therapy. The stuttering rate and mean length of the three longest stuttering events were studied four times in videos of interviews, reading texts and three telephone calls. Outcomes are reported for the 56 children and young adults who stuttered and who completed D.E.L.P.H.I.N. The main analysis was performed using linear mixed models.
RESULTS: Quality of life as measured in the Strength and Difficulties Questionnaire (SDQ) - filled in by the participants/their parents - increased significantly from before the start of the therapy to 1 year after completion of the therapy. The subjective rating of the impact of stuttering also improved significantly. The stuttering rate and mean length of the longest stuttering event decreased significantly for all three modes from pre-treatment to 12 months post-treatment.
CONCLUSIONS: After D.E.L.P.H.I.N., a significant improvement of the relevant endpoints quality of life, impact of stuttering, and severity of stuttering is observed.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app